Every one of those 1 sits in a single category, funding. Gaudium IVF is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The 5 average consequence score is below the beat benchmark of 6 in the same window.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Gaudium IVF and Women Health
Every one of those 1 sits in a single category, funding. Gaudium IVF is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. The 5 average consequence score is below the beat benchmark of 6 in the same window. Source depth averages 2 original sources per story, versus 2.4 across the same-window beat baseline. We currently track 1 Healthcare story that mention Gaudium IVF and Women Health, all published on February 24, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 26 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Gaudium IVF and Women Health. Shared-story counts are live from our verified record — not editorial picks.
Gaudium IVF and Women Health's initial public offering has reached its final day of bidding, showing robust investor interest with a 3x subscription rate by the end of Day 2. The offering is currently trading at a 6.33% premium in the grey market, reflecting positive sentiment toward the specialized fertility services sector in India.